News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,992 Results
Type
Article (42416)
Company Profile (294)
Press Release (674282)
Multimedia
Podcasts (77)
Webinars (12)
Section
Business (210409)
Career Advice (2091)
Deals (36627)
Drug Delivery (107)
Drug Development (83040)
Employer Resources (175)
FDA (16563)
Job Trends (15403)
News (355990)
Policy (33905)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2597)
Accelerated approval (5)
Adcomms (21)
Allergies (86)
Alliances (51405)
ALS (90)
Alzheimer's disease (1387)
Antibody-drug conjugate (ADC) (120)
Approvals (16562)
Artificial intelligence (257)
Autoimmune disease (22)
Automation (15)
Bankruptcy (371)
Best Places to Work (11770)
BIOSECURE Act (19)
Biosimilars (110)
Biotechnology (188)
Bladder cancer (60)
Brain cancer (28)
Breast cancer (265)
Cancer (2116)
Cardiovascular disease (175)
Career advice (1750)
Career pathing (30)
CAR-T (145)
Cell therapy (409)
Cervical cancer (19)
Clinical research (67385)
Collaboration (813)
Compensation (511)
Complete response letters (25)
COVID-19 (2654)
CRISPR (43)
C-suite (230)
Cystic fibrosis (103)
Data (2061)
Decentralized trials (2)
Denatured (27)
Depression (42)
Diabetes (260)
Diagnostics (6433)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (122)
Drug pricing (108)
Drug shortages (28)
Duchenne muscular dystrophy (92)
Earnings (88030)
Editorial (36)
Employer branding (21)
Employer resources (149)
Events (114769)
Executive appointments (707)
FDA (17763)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (728)
Gene editing (107)
Generative AI (21)
Gene therapy (301)
GLP-1 (738)
Government (4525)
Grass and pollen (4)
Guidances (51)
Healthcare (18995)
Huntington's disease (24)
IgA nephropathy (25)
Immunology and inflammation (119)
Indications (27)
Infectious disease (2795)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (93)
Interviews (322)
IPO (16772)
IRA (47)
Job creations (4055)
Job search strategy (1492)
Kidney cancer (9)
Labor market (36)
Layoffs (482)
Leadership (17)
Legal (8375)
Liver cancer (73)
Lung cancer (304)
Lymphoma (141)
Machine learning (5)
Management (59)
Manufacturing (294)
MASH (64)
Medical device (13427)
Medtech (13432)
Mergers & acquisitions (20366)
Metabolic disorders (679)
Multiple sclerosis (75)
NASH (17)
Neurodegenerative disease (88)
Neuropsychiatric disorders (26)
Neuroscience (1913)
NextGen: Class of 2025 (6637)
Non-profit (4524)
Northern California (2540)
Now hiring (38)
Obesity (368)
Opinion (228)
Ovarian cancer (74)
Pain (90)
Pancreatic cancer (81)
Parkinson's disease (147)
Partnered (21)
Patents (227)
Patient recruitment (100)
Peanut (49)
People (59184)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20898)
Phase II (29643)
Phase III (22227)
Pipeline (1127)
Policy (140)
Postmarket research (2654)
Preclinical (8859)
Press Release (68)
Prostate cancer (99)
Psychedelics (31)
Radiopharmaceuticals (249)
Rare diseases (388)
Real estate (6257)
Recruiting (67)
Regulatory (23058)
Reports (46)
Research institute (2368)
Resumes & cover letters (358)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (73)
Series A (127)
Series B (82)
Service/supplier (12)
Sickle cell disease (55)
Southern California (2191)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (29)
Startups (3722)
State (2)
Stomach cancer (14)
Supply chain (66)
Tariffs (26)
The Weekly (48)
United States (22219)
Vaccines (685)
Venture capitalists (38)
Weight loss (248)
Women's health (34)
Worklife (15)
Date
Today (106)
Last 7 days (497)
Last 30 days (2531)
Last 365 days (33511)
2025 (9332)
2024 (35770)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (781)
Alabama (52)
Alaska (7)
Arizona (236)
Arkansas (14)
Asia (40634)
Australia (6513)
California (5810)
Canada (1949)
China (502)
Colorado (255)
Connecticut (263)
Delaware (137)
Europe (86712)
Florida (863)
Georgia (202)
Idaho (57)
Illinois (525)
India (26)
Indiana (308)
Iowa (9)
Japan (152)
Kansas (102)
Kentucky (23)
Louisiana (9)
Maine (62)
Maryland (865)
Massachusetts (4393)
Michigan (217)
Minnesota (380)
Mississippi (2)
Missouri (78)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1674)
New Mexico (29)
New York (1658)
North Carolina (956)
North Dakota (7)
Northern California (2540)
Ohio (194)
Oklahoma (14)
Oregon (38)
Pennsylvania (1311)
Puerto Rico (11)
Rhode Island (30)
South America (1162)
South Carolina (19)
South Dakota (1)
Southern California (2191)
Tennessee (99)
Texas (869)
Utah (173)
Virginia (143)
Washington D.C. (59)
Washington State (539)
West Virginia (3)
Wisconsin (53)
716,992 Results for "aridis pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Aridis Provides Corporate Update - June 24, 2024
Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced a corporate update on recent developments.
June 24, 2024
·
8 min read
Press Releases
Aridis Provides Corporate Update
December 20, 2024
·
9 min read
Biotech Bay
Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until January 12, 2024
Aridis Pharmaceuticals, Inc. (OTC QB: ARDS) today announced that its 2023 Annual Meeting of Stockholders (“Annual Meeting”), scheduled for Friday, December 15, 2023, was convened and adjourned, without any business being conducted, due to lack of the requisite quorum.
December 15, 2023
·
6 min read
Business
Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update
Aridis Pharmaceuticals, Inc. (OTCQB: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today reported financial and corporate results for its third quarter ended September 30, 2023.
November 3, 2023
·
13 min read
Deals
Aridis Pharmaceuticals Announces $2 Million Offering
Aridis Pharmaceuticals, Inc. today announced the pricing of an offering of 10,000,000 shares of the Company’s common stock (or pre-funded warrants in lieu thereof) and accompanying warrants to purchase up to 10,000,000 shares of common stock at a combined offering price of $0.20 per share.
August 2, 2023
·
7 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
Business
Aridis Pharmaceuticals Announces First Quarter 2023 Financial Results and Business Update
Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today reported financial and corporate results for its first quarter ended March 31, 2023.
June 8, 2023
·
14 min read
Biotech Bay
Aridis Provides Corporate Update
Aridis Pharmaceuticals, Inc., a biopharmaceutical company, announced a corporate update on recent developments.
March 31, 2023
·
7 min read
Press Releases
Universe Pharmaceuticals INC Announces Share Consolidation
March 20, 2025
·
3 min read
Biotech Bay
Aridis Pharmaceuticals’ AR-301 Eligible for Consideration under FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD)
Aridis Pharmaceuticals, Inc. today announced that its AR-301 clinical program has been deemed eligible for consideration under the U.S. Food and Drug Administration’s (FDA) Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD).
June 20, 2023
·
6 min read
1 of 71,700
Next
